Toxicological profile of lipid-based nanostructures: are they considered as completely safe nanocarriers?

被引:49
作者
Azarnezhad, Asaad [1 ]
Samadian, Hadi [2 ]
Jaymand, Mehdi [3 ]
Sobhani, Mahsa [4 ]
Ahmadi, Amirhossein [5 ]
机构
[1] Kurdistan Univ Med Sci, Res Inst Hlth Dev, Liver & Digest Res Ctr, Sanandaj, Iran
[2] Kermanshah Univ Med Sci, Hlth Inst, Pharmaceut Sci Res Ctr, Kermanshah, Iran
[3] Kermanshah Univ Med Sci, Hlth Technol Inst, Nano Drug Delivery Res Ctr, Kermanshah, Iran
[4] Kermanshah Univ Med Sci, Hlth Technol Inst, Med Biol Res Ctr, Kermanshah, Iran
[5] Mazandaran Univ Med Sci, Pharmaceut Sci Res Ctr, Fac Pharm, Sari, Iran
关键词
Nanotechnology; lipid-based nanomaterials; genotoxicity; epigenicity; cytotoxicity; nanomaterials exposure routs; ENHANCED TRANSDERMAL DELIVERY; PEGYLATED LIPOSOMAL DOXORUBICIN; CONTROLLED DRUG-DELIVERY; IN-VITRO; NANOPARTICLES SLN; DNA-DAMAGE; CATIONIC LIPIDS; CELLULAR UPTAKE; OXIDATIVE STRESS; REACTIVE OXYGEN;
D O I
10.1080/10408444.2020.1719974
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Nanoparticles are ubiquitous in the environment and are widely used in medical science (e.g. bioimaging, diagnosis, and drug therapy delivery). Due to unique physicochemical properties, they are able to cross many barriers, which is not possible for traditional drugs. Nevertheless, exposure to NPs and their following interactions with organelles and macromolecules can result in negative effects on cells, especially, they can induce cytotoxicity, epigenicity, genotoxicity, and cell death. Lipid-based nanomaterials (LNPs) are one of the most important achievements in drug delivery mainly due to their superior physicochemical and biological characteristics, particularly its safety. Although they are considered as the completely safe nanocarriers in biomedicine, the lipid composition, the surfactant, emulsifier, and stabilizer used in the LNP preparation, and surface electrical charge are important factors that might influence the toxicity of LNPs. According to the author's opinion, their toxicity profile should be evaluated case-by-case regarding the intended applications. Since there is a lack of all-inclusive review on the various aspects of LNPs with an emphasis on toxicological profiles including cyto-genotoxiciy, this comprehensive and critical review is outlined.
引用
收藏
页码:148 / 176
页数:29
相关论文
共 237 条
[1]   Scaffolding polymeric biomaterials: Are naturally occurring biological macromolecules more appropriate for tissue engineering? [J].
Abbasian, Mojtaba ;
Massoumi, Bakhshali ;
Mohammad-Rezaei, Rahim ;
Samadian, Hadi ;
Jaymand, Mehdi .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 134 (673-694) :673-694
[2]   Histological alterations in the liver of rats induced by different gold nanoparticle sizes, doses and exposure duration [J].
Abdelhalim, Mohamed Anwar K. ;
Jarrar, Bashir M. .
JOURNAL OF NANOBIOTECHNOLOGY, 2012, 10
[3]  
Abdella EM, 2012, IRAN J CANCER PREV, V5, P51
[4]   Transfersomal Nanoparticles for Enhanced Transdermal Delivery of Clindamycin [J].
Abdellatif, Ahmed A. H. ;
Tawfeek, Hesham M. .
AAPS PHARMSCITECH, 2016, 17 (05) :1067-1074
[5]   Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials [J].
Abdulbaqi, Ibrahim M. ;
Darwis, Yusrida ;
Khan, Nurzalina Abdul Karim ;
Abou Assi, Reem ;
Khan, Arshad A. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2016, 11 :2279-2304
[6]   Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment [J].
Abidin, Lubna ;
Mujeeb, Mohammed ;
Imam, Syed Sarim ;
Aqil, Mohammed ;
Khurana, Deepak .
DRUG DELIVERY, 2016, 23 (03) :1079-1084
[7]  
Agarwal M., 2013, Int J Curr Microbiol Appl Sci, V2, P76
[8]   FRET-Labeled siRNA Probes for Tracking Assembly and Disassembly of siRNA Nanocomplexes [J].
Alabi, Christopher A. ;
Love, Kevin T. ;
Sahay, Gaurav ;
Stutzman, Tina ;
Young, Whitney T. ;
Langer, Robert ;
Anderson, Daniel G. .
ACS NANO, 2012, 6 (07) :6133-6141
[9]  
Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
[10]   HPRT mutations in humans:: biomarkers for mechanistic studies [J].
Albertini, RJ .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2001, 489 (01) :1-16